Jun Okada
President chez 3-D MATRIX, LTD.
Fortune : 169 836 $ au 31/03/2024
Profil
Jun Okada is currently the President & Representative Director at 3-D Matrix Ltd.
He is also a Director at 3-D Matrix, Inc., 3-D Matrix Da America Latina Representacão Comercial Ltda., 3-D Matrix Asia Pte.
Ltd., 3-D Matrix Europe SAS, and Beijing 3-D Matrix Investment Consulting, Ltd.
Mr. Okada has an MBA from INSEAD and a graduate degree from the University of Tokyo Faculty of Law & Graduate Schools for Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
3-D MATRIX, LTD.
0,26% | 30/04/2023 | 204 000 ( 0,26% ) | 169 836 $ | 31/03/2024 |
Postes actifs de Jun Okada
| Sociétés | Poste | Début |
|---|---|---|
| 3-D MATRIX, LTD. | President | 01/03/2016 |
| 3-D Matrix Asia Pte. Ltd. | Director/Board Member | 01/10/2012 |
3-D Matrix Da America Latina Representacão Comercial Ltda.
 3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Director/Board Member | 01/06/2014 |
| Beijing 3-D Matrix Investment Consulting, Ltd. | Director/Board Member | 01/08/2014 |
3-D Matrix Europe SAS
 3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The private company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Director/Board Member | 01/04/2012 |
| 3-D Matrix, Inc. | Director/Board Member | 01/04/2016 |
Formation de Jun Okada
| INSEAD | Masters Business Admin |
| University of Tokyo Faculty of Law & Graduate Schools for Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| 3-D MATRIX, LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| 3-D Matrix, Inc. | |
3-D Matrix Da America Latina Representacão Comercial Ltda.
3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Health Technology |
| 3-D Matrix Asia Pte. Ltd. | |
3-D Matrix Europe SAS
3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The private company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Health Technology |
| Beijing 3-D Matrix Investment Consulting, Ltd. |
